Biostar Pharmaceuticals, Inc.
BSPM · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $3,229 | $4,035 | $6,091 | $7,492 |
| - Cash | $365 | $407 | $484 | $173 |
| + Debt | $2,427 | $2,381 | $2,344 | $2,326 |
| Enterprise Value | $5,291 | $6,008 | $7,951 | $9,644 |
| Revenue | $0 | $0 | $0 | $318 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$37 |
| % Margin | – | – | – | -11.6% |
| EBITDA | $222 | -$987 | -$671 | $6,333 |
| % Margin | – | – | – | 1,992.8% |
| Net Income | -$125 | -$1,314 | -$1,014 | $3,388 |
| % Margin | – | – | – | 1,066.1% |
| EPS Diluted | -0.05 | -0.5 | -0.38 | 1.61 |
| % Growth | 90% | -31.6% | -123.6% | – |
| Operating Cash Flow | -$1 | $4,266 | $321 | $4,002 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | $4,266 | $321 | $4,002 |